Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowTransplantation ConditioningBone Marrow CellsHematopoietic Stem Cell TransplantationWhole-Body IrradiationLeukemiaTransplantation, AutologousTissue DonorsTransplantation ChimeraAnemia, AplasticGraft SurvivalHematologic NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesCytomegalovirus InfectionsRecurrenceImmunosuppressive AgentsLeukemia, Myeloid, AcuteHistocompatibility TestingLymphocyte DepletionBusulfanHistocompatibilityPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, IsogeneicLiver TransplantationRemission InductionTreatment OutcomeHematopoietic Stem CellsAcute DiseaseNuclear FamilyLymphocyte TransfusionTime FactorsCyclosporineKidney TransplantationGraft vs Tumor EffectGraft RejectionCombined Modality TherapyT-LymphocytesImmunosuppressionRadiation ChimeraSurvival AnalysisCyclophosphamideBone Marrow PurgingRetrospective StudiesMice, Inbred C57BLStem Cell TransplantationGraft vs Host ReactionTransplantation ImmunologyLeukocyte TransfusionLeukemia, MyeloidHepatic Veno-Occlusive DiseaseGraft vs Leukemia EffectHematopoiesisMyelodysplastic SyndromesBone Marrow DiseasesCytomegalovirusHLA AntigensHeart TransplantationBone Marrow ExaminationChimeraSurvival RatePeripheral Blood Stem Cell TransplantationLymphoma, Non-HodgkinBone RemodelingMultiple MyelomaHematologic DiseasesMice, Inbred BALB CGranulocyte Colony-Stimulating FactorLung TransplantationBone Marrow NeoplasmsDisease-Free SurvivalFatal OutcomeFollow-Up StudiesImmunocompromised HostAntigens, CD34Actuarial AnalysisAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayOpportunistic InfectionsSevere Combined ImmunodeficiencySpleenHematopoietic Stem Cell MobilizationOrgan TransplantationBone DensityBlood CellsLymphomaLeukocyte CountCell DifferentiationAntilymphocyte SerumFlow CytometrySkin TransplantationCord Blood Stem Cell TransplantationPrognosisTransplantationInfectionGanciclovirSalvage Therapy